A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

 

A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Dr. Zielsdorf lists lifestyle modifications for patients seeking to optimize fertility, and major reasons for idiopathic infertility. She describes how LDN and other therapies can support fertility. LDN is safe for pregnancy and breastfeeding and poses no risk for fetuses. She provides the LDN dosing strategy for infertile patients, and an approach to pregnancy. There are clinically many benefits possible with LDN in pregnancy, and she uses it for several listed conditions. She includes several case studies in support of her presentation.

KEYWORDS:  infertility, low dose naltrexone (LDN), pregnancy, hormone, thyroid, sleep, nutrition, zinc, endorphins, IBS, dysbiosis, endometriosis, PMS, PCOS, anxiety, autoimmune, rheumatoid arthritis, Hashimoto’s

This is a summary of the presentation. Click on the video for full information.